The physical, emotional and interpersonal impact of HAART: exploring the realities of HIV seropositive individuals on combination therapy (Q40427185)

20 September 2017

The physical, emotional and interpersonal impact of HAART: exploring the realities of HIV seropositive individuals on combination therapy (English)

1 reference

20 September 2017

Perry N Halkitis

1

1 reference

20 September 2017

Michael T Shrem

series ordinal

2

1 reference

20 September 2017

David D Zade

series ordinal

3

1 reference

20 September 2017

Leo Wilton

series ordinal

4

1 reference

20 September 2017

1 May 2005

1 reference

Journal of Health Psychology

20 September 2017

1 reference

20 September 2017

10

1 reference

20 September 2017

345-358

1 reference

20 September 2017

3

1 reference

Trust and the acceptance of and adherence to antiretroviral therapy

20 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Impact of lipodystrophy on the quality of life of HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

HIV-1 drug resistance: can we overcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Combination antiretroviral therapy and improvements in mental health: results from a nationally representative sample of persons undergoing care for HIV in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Medication Adherence Among HIV-Infected Patients: Understanding the Complex Behavior of Patients Taking This Complex Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Extent of human immunodeficiency virus type 1 drug resistance as a predictor of virological failure after genotype-guided treatment switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Home-based study of anti-HIV drug regimen adherence among HIV-infected women: feasibility and preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

The experience of taking multiple drug therapies for persons with HIV infection: the Canadian perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

The relationship of disease severity, health beliefs and medication adherence among HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Factors associated with the use of highly active antiretroviral therapy in patients newly entering care in an urban clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Adherence to HIV medications in a cohort of men who have sex with men: impact of September 11th

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

The RAND-36 measure of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

HIV-seropositive individuals' optimistic beliefs about prognosis and relation to medication and safe sex adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Adherence to HAART among patients with HIV: breakthroughs and barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Investigating the psychosocial impact of anti-HIV combination therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

The impact of religion on adherence with antiretrovirals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Sexual behavior changes and protease inhibitor therapy. SEROCO Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Pain and other symptoms in ambulatory HIV patients in the age of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Personality, quality of life and HAART adherence among men and women living with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

A 'second life' agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Psychological effects of HAART: a 2-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Psychological and existential issues and quality of life in people living with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Longitudinal use of phenotypic resistance testing to HIV-1 protease inhibitors in patients developing HAART failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Psychological burden in the era of HAART: impact of selenium therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Challenges in the management of the HIV patient in the third decade of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

HIV treatments optimism and sexual behaviour among gay men in Sydney and Melbourne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359105305051421

21 January 2018

Identifiers

DOI

10.1177/1359105305051421

1 reference

20 September 2017

1 reference